Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析

◆英語タイトル:Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review
◆商品コード:GDME6306SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥54,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Oxford Nanopore Technologies Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., develops disruptive, electronic, and single-molecule sensing system. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, the UK.

Oxford Nanopore Technologies Ltd Key Recent Developments

Nov 30,2020: RevoluGen: Fire Monkey v8 HMW DNA extraction delivers 30Gb+ yield from sequencing on the ONT MinION
Oct 28,2020: Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
Jun 09,2020: G42 and ONT co-develop ultra-scalable solution for COVID-19 detection
Mar 23,2020: UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network
Mar 18,2020: Statement on Jury Verdict in delaware trial against Oxford Nanopore Technologies

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Oxford Nanopore Technologies Ltd – Key Facts
Oxford Nanopore Technologies Ltd – Key Employees
Oxford Nanopore Technologies Ltd – Key Employee Biographies
Oxford Nanopore Technologies Ltd – Major Products and Services
Oxford Nanopore Technologies Ltd – History
Oxford Nanopore Technologies Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Oxford Nanopore Technologies Ltd – Business Description
Oxford Nanopore Technologies Ltd – SWOT Analysis
SWOT Analysis – Overview
Oxford Nanopore Technologies Ltd – Strengths
Oxford Nanopore Technologies Ltd – Weaknesses
Oxford Nanopore Technologies Ltd – Opportunities
Oxford Nanopore Technologies Ltd – Threats
Oxford Nanopore Technologies Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Oxford Nanopore Technologies Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 30, 2020: RevoluGen: Fire Monkey v8 HMW DNA extraction delivers 30Gb+ yield from sequencing on the ONT MinION
Oct 28, 2020: Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
Jun 09, 2020: G42 and ONT co-develop ultra-scalable solution for COVID-19 detection
Mar 23, 2020: UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network
Mar 18, 2020: Statement on Jury Verdict in delaware trial against Oxford Nanopore Technologies
Jan 31, 2020: 200 Oxford Nanopore sequencers have left UK for China, to support rapid, near-sample coronavirus sequencing for outbreak surveillance
Jan 31, 2020: Oxford Nanopore sequencers have left UK for China, to support rapid, near-sample coronavirus sequencing for outbreak surveillance
Jan 10, 2020: Oxford Nanopore appoints John O’Higgins to Board
Jul 17, 2019: Oxford Nanopore prevails for fourth time in patent hearing
Apr 25, 2019: GrandOmics collaborates with Oxford Nanopore to deliver dbSV-100k, a project to sequence 100,000 affordable nanopore long-read human genomes
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Oxford Nanopore Technologies Ltd, Key Facts
Oxford Nanopore Technologies Ltd, Key Employees
Oxford Nanopore Technologies Ltd, Key Employee Biographies
Oxford Nanopore Technologies Ltd, Major Products and Services
Oxford Nanopore Technologies Ltd, History
Oxford Nanopore Technologies Ltd, Other Locations
Oxford Nanopore Technologies Ltd, Key Competitors
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Oxford Nanopore Technologies Ltd, Recent Deals Summary

★海外企業調査レポート[Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • FTI Consulting Inc (FCN):企業の財務・戦略的SWOT分析
    Summary FTI Consulting Inc (FTI) is an independent global consulting service provider. The company offers corporate finance and restructuring, consulting, strategic communications, economic consulting, forensic and litigation, technology and specialty services. It provides it services across various …
  • Danone SA:企業の戦略・SWOT・財務情報
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Aesculap Inc-医療機器分野:企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • LHC Group Inc (LHCG):企業の財務・戦略的SWOT分析
    Summary LHC Group Inc (LHC Group) is an in-home healthcare service provider. The center offers home health, hospice, personal care services and facility-based services. It covers a range of healthcare needs for patients and families dealing with injury, illness, and chronic conditions. LHC Group pro …
  • Bank Frick & Co. AG:企業の戦略・SWOT・財務情報
    Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CNP Assurances SA:企業のM&A・事業提携・投資動向
    CNP Assurances SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CNP Assurances SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Merit Medical Systems Inc (MMSI):企業の財務・戦略的SWOT分析
    Merit Medical Systems Inc (MMSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Siemens Gamesa Renewable Energy S.A.:企業の戦略・SWOT・財務情報
    Siemens Gamesa Renewable Energy S.A. - Strategy, SWOT and Corporate Finance Report Summary Siemens Gamesa Renewable Energy S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Dolphin Hotels plc:企業の戦略・SWOT・財務分析
    Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report Summary Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kissei Pharmaceutical Co Ltd (4547):製薬・医療:M&Aディール及び事業提携情報
    Summary Kissei Pharmaceutical Co Ltd (Kissei) discovers, manufactures and sells a range of innovative pharmaceutical products and develops. The company's pharmaceutical products include urological medicine, metabolic endocrinology medicine, drugs for kidney and dialysis department, drug for obstetri …
  • Pt Bumi Resources Tbk:企業の戦略・SWOT・財務分析
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Consumers Energy Company-エネルギー分野:企業M&A・提携分析
    Summary Consumers Energy Company (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates …
  • Essar Steel Ltd:企業の戦略・SWOT・財務情報
    Essar Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary Essar Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • VAMED AG:企業の戦略・SWOT・財務情報
    VAMED AG - Strategy, SWOT and Corporate Finance Report Summary VAMED AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆